Reproductive Health Matters
Volume 17, Issue 33 , Pages 120-132 , May 2009

Exploring the costs and economic consequences of unsafe abortion in Mexico City before legalisation

  • Carol Levin

      Affiliations

    • Senior Health Economist, Program for Appropriate Technology in Health (PATH), Seattle WA, USA
    • ,
  • Daniel Grossman

      Affiliations

    • Senior Associate, Ibis Reproductive Health, Oakland CA, USA
    • ,
  • Karla Berdichevsky

      Affiliations

    • Research Coordinator (at the time of the study), Population Council Mexico Office, Mexico City, Mexico
    • ,
  • Claudia Diaz

      Affiliations

    • Research Coordinator (at the time of the study), Population Council Mexico Office, Mexico City, Mexico
    • ,
  • Belkis Aracena

      Affiliations

    • Researcher, Department of Health Economics and Policy, National Institute of Public Health, Cuernavaca, Mexico
    • ,
  • Sandra G Garcia

      Affiliations

    • Director, Population Council Mexico Office, Mexico City, Mexico
    • ,
  • Lorelei Goodyear

      Affiliations

    • Senior Program Officer, PATH, Seattle WA, USA

References 

  1. Lara D, Garcia SG, Strickler J, et al. El acceso al aborto legal de las mujeres embarazadas por violación en la ciudad de México. Gaceta Médica de México. 2003;139(1):S77–S90
  2. Alan Guttmacher Institute. Aborto clandestino: una realidad latinoamericana. Fact sheet. New York: Allan Guttmacher Institute; 1994;
  3. Espinoza H, Abuabara K, Ellertson C. Physicians' knowledge and opinions about medication abortion in four Latin American and Caribbean region countries. Contraception. 2004;70(2):127–133
  4. Sherris J, Bingham A, Burns MA, et al. Misoprostol use in developing countries: results from a multicountry study. International Journal of Gynecology and Obstetrics. 2005;88(1):76–81
  5. Lara D, Abuabara K, Grossman D, et al. Pharmacy provision of medical abortifacients in a Latin American city. Contraception. 2006;74(5):394–399
  6. Billings DL, Benson J. Postabortion care in Latin America: policy and service recommendations from a decade of operations research. Health Policy and Planning. 2005;20(3):158–166
  7. Faúndes A, Santos LC, Carvalho M, et al. Post-abortion complications after interruption of pregnancy with misoprostol. Advances in Contraception. 1996;12(1):1–9
  8. Walker D, Campero L, Espinoza H, et al. Deaths from complications of unsafe abortion: misclassified second trimester deaths. Reproductive Health Matters. 2004;12(24 Suppl):27–38
  9. Juarez F, Singh S, Garcia SG, et al. Estimates of induced abortion in Mexico: what's changed between 1990 and 2006?. International Family Planning Perspectives. 2008;34(4):158–168
  10. Henshaw SK, Adewole I, Singh S, et al. Severity and cost of unsafe abortion complications treated in Nigerian hospitals. International Family Planning Perspectives. 2008;34(1):40–50
  11. World Health OrganizationDepartment of Reproductive Health and Research. Mother-Baby Package Costing Spreadsheet Version 1.01. Geneva: WHO; 1999;
  12. Mexican Ministry of Health. Automated Hospital Discharge Records System 2004. Mexico City: Mexican MoH; 2005;
  13. Instituto Mexicano del Seguro Social. Hospital Release Records Database 2004. Mexico City: IMSS; 2005;
  14. Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado. Hospital Release Records, Mexico 2004. Mexico City: ISSSTE; 2005;
  15. Berer M. National laws and unsafe abortion: the parameters of change. Reproductive Health Matters. 2004;12(24 Suppl):1–8
  16. World Health Organization. Safe abortion: technical and policy guidance for health systems. Geneva: WHO; 2003;
  17. Brambila C, Langer A, Garcia-Barrios C, et al. Estimating costs of postabortion services at Dr. Aurelio Valdivieso General Hospital, Oaxaca, Mexico. In:  Huntington D,  Piet-Pelon NJ editor. Postabortion Care: Lessons from Operations Research. New York: Population Council; 1999;p. 108–124
  18. Johnson BR, Benson J, Bradley J, et al. Costs and resource utilization for the treatment of incomplete abortion in Kenya and Mexico. Social Science and Medicine. 1993;36:1443–1453
  19. Billings DL. Misoprostol alone for early medical abortion in a Latin American clinic setting. Reproductive Health Matters. 2004;12(24 Suppl):57–64
  20. Clark WH, Gold M, Grossman D, et al. Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research. Contraception. 2007;75(4):245–250
  21. Afable-Munsuz A, Gould H, Stewart F, et al. Provider practice models for and costs of delivering medication abortion – evidence from 11 US abortion care settings. Contraception. 2007;75(1):45–51
  22. Sánchez Fuentes ML, Paine J, Elliott-Buettner B. The decriminalisation of abortion in Mexico City: how did abortion rights become a political priority?. Gender & Development. 2008;16(2):345–360

PII: S0968-8080(09)33432-1

doi: 10.1016/S0968-8080(09)33432-1

Reproductive Health Matters
Volume 17, Issue 33 , Pages 120-132 , May 2009

Article Tools

* Image Usage & Resolution